Showing 1,361 - 1,380 results of 1,680 for search '"myocardial"', query time: 0.06s Refine Results
  1. 1361

    Advancements in Managing Anthracycline-Induced Cardiotoxicity: Insights from Interventional Clinical Trials by Zhao M, Zhang X, Zhou D, Song J

    Published 2025-01-01
    “…Mei Zhao,1 Xiaohong Zhang,1 Dongyang Zhou,2 Junxian Song3– 5 1Department of Pharmacy, Peking University People’s Hospital, Beijing, People’s Republic of China; 2Department of Metabolism, Digestion and Reproduction, Faculty of Medicine, Imperial College London, London, UK; 3Department of Cardiology, Peking University People’s Hospital, Beijing, People’s Republic of China; 4Beijing Key Laboratory of Early Prediction and Intervention of Acute Myocardial Infarction, Peking University People’s Hospital, Beijing, People’s Republic of China; 5Center for Cardiovascular Translational Research, Peking University People’s Hospital, Beijing, People’s Republic of ChinaCorrespondence: Junxian Song, Department of Cardiology, Peking University People’s Hospital, No. 11 Xizhimen South Street, Xicheng District, Beijing, 100044, People’s Republic of China, Email sjx221@163.comPurpose: Anthracycline-induced cardiotoxicity (AIC) is a significant complication in cancer treatment, impacting long-term health outcomes. …”
    Get full text
    Article
  2. 1362

    Midterm Clinical Impacts of Biodegradable Polymer Everolimus-Eluting Stents Compared with Durable Polymer Everolimus-Eluting Stents: A 3-Year Propensity-Matched Study by Hiroaki Matsuda, Ai Kagase, Takahiro Tokuda, Yusuke Ochiumi, Akira Murata, Yoriyasu Suzuki, Tatsuya Ito

    Published 2020-01-01
    “…The primary endpoint was a 3-year cumulative incidence of target lesion failure (TLF) defined as cardiac death, target vessel myocardial infarction (MI), and clinical indicated target lesion revascularization (TLR). …”
    Get full text
    Article
  3. 1363

    Understanding the impact of racism on surgical outcomes in settler nation-states USA and Canada: a protocol for a systematic review and meta-analysis by Mary Brindle, Oluwatomilayo Daodu, Tyara Marchand, Saffa Aziz, Ifeoluwa Adedipe, Mirna Matta

    Published 2025-01-01
    “…The outcomes will be mortality, length of stay in hospital, readmission, reoperation, wound dehiscence, surgical site infection, pulmonary embolism, sepsis or septic shock, pneumonia, blood transfusion, stroke, myocardial infarction and bile duct injury. Summary estimates of cumulative incidence, prevalence, incidence rate and occurrence rate of complications using DerSimonian and Laird random effects models will be calculated for the systematic review and meta-analysis. …”
    Get full text
    Article
  4. 1364

    EKOS™ Jena Experience: Safety, Feasibility, and Midterm Outcomes of Percutaneous Ultrasound-Assisted Catheter-Directed Thrombolysis in Patients with Intermediate-High-Risk or High-... by Friederike Klein, Sven Möbius-Winkler, Laura Bäz, Rüdiger Pfeifer, Michael Fritzenwanger, Stefan Heymel, Marcus Franz, Pawel Aftanski, P. Christian Schulze, Daniel Kretzschmar

    Published 2022-01-01
    “…There were 6 major bleeding events resulting in transfusion. No stroke, myocardial infarction, right heart decompensation, or recurrent PE occurred. 31 patients (63%) were discharged without any signs of right ventricular stress. …”
    Get full text
    Article
  5. 1365

    Bioinformatics and System Biological Approaches for the Identification of Genetic Risk Factors in the Progression of Cardiovascular Disease by Joy Dip Barua, Shudeb Babu Sen Omit, Humayan Kabir Rana, Nitun Kumar Podder, Utpala Nanda Chowdhury, Md Habibur Rahman

    Published 2022-01-01
    “…Cardiovascular disease (CVD) is the combination of coronary heart disease, myocardial infarction, rheumatic heart disease, and peripheral vascular disease of the heart and blood vessels. …”
    Get full text
    Article
  6. 1366

    Inhibiting C-Reactive Protein for the Treatment of Cardiovascular Disease: Promising Evidence from Rodent Models by Alexander J. Szalai, Mark A. McCrory, Dongqi Xing, Fadi G. Hage, Andrew Miller, Suzanne Oparil, Yiu-Fai Chen, Michelle Mazzone, Richard Early, Scott P. Henry, Thomas A. Zanardi, Mark J. Graham, Rosanne M. Crooke

    Published 2014-01-01
    “…Notably, this effect was associated with improved heart function and pathology following myocardial infarction (induced by ligation of the left anterior descending artery). …”
    Get full text
    Article
  7. 1367

    Pharmacological or genetic inhibition of LTCC promotes cardiomyocyte proliferation through inhibition of calcineurin activity by Lynn A. C. Devilée, Abou bakr M. Salama, Jessica M. Miller, Janice D. Reid, Qinghui Ou, Nourhan M. Baraka, Kamal Abou Farraj, Madiha Jamal, Yibing Nong, Todd K. Rosengart, Douglas Andres, Jonathan Satin, Tamer M. A. Mohamed, James E. Hudson, Riham R. E. Abouleisa

    Published 2025-01-01
    “…Moreover, ectopic expression of RRAD/CDK4/CCND in combination induced CM proliferation in vitro and in vivo, improved cardiac function and reduced scar size post-myocardial infarction.…”
    Get full text
    Article
  8. 1368

    Visit-to-visit lipid variability on long-term major adverse cardiovascular events: a prospective multicentre cohort from the CORE-Thailand registry by Chutithep Teekaput, Kitti Thiankhaw, Wanwarang Wongcharoen, Narawudt Prasertwitayakij, Siriluck Gunaparn, Arintaya Phrommintikul

    Published 2025-01-01
    “…The primary outcome was 4-point MACE, including non-fatal myocardial infarction, non-fatal stroke, heart failure hospitalisation, and all-cause mortality. …”
    Get full text
    Article
  9. 1369

    Lipoprotein(a) and thromboembolism: current state of knowledge and unsolved issues by Małgorzata Konieczyńska, Joanna Natorska, Michał Ząbczyk, Anetta Undas

    Published 2024-12-01
    “…Elevated Lp(a) levels, found in about 20% of Europeans, are strongly linked to higher rates of myocardial infarction, major adverse cardiac events, accelerated plaque progression, ischemic stroke (especially in younger adults), and calcific aortic valve disease. …”
    Get full text
    Article
  10. 1370

    The GRACE Scale in the Prognosis of Patients with Takotsubo Syndrome by Malgorzata Zalewska-Adamiec, Lukasz Kuzma, Slawomir Dobrzycki, Hanna Bachorzewska-Gajewska

    Published 2020-01-01
    “…The prognosis of Takotsubo syndrome (TTS) is comparable to that of the non-ST-elevation myocardial infarction (NSTEMI). The GRACE scale is used to assess the risk of premature and long-term mortality in patients with NSTEMI in order to select the most favorable treatment strategy. …”
    Get full text
    Article
  11. 1371

    Demographics and regional trends of ischemic heart disease-related mortality in older adults in the United States, 1999-2020. by Fakhar Latif, Muhammad Moiz Nasir, Wajeeh Ur Rehman, Mohammed Hamza, Jishanth Mattumpuram, Komail Khalid Meer, Helme Silvet, Alon Yarkoni, Mouhamed Amr Sabouni, Nabil Braiteh, Keyoor Patel, Abdulqadir J Nashwan

    Published 2025-01-01
    “…Chronic IHD (1552.0) consistently showed the highest AAMRs throughout the study, surpassing myocardial infarction (515.6), other ischemic heart diseases (24.0), and angina pectoris (5.6).…”
    Get full text
    Article
  12. 1372

    Machine learning-driven prediction of medical expenses in triple-vessel PCI patients using feature selection by Kuan-Yu Chen, Yen-Chun Huang, Chih-Kuang Liu, Shao-Jung Li, Mingchih Chen

    Published 2025-01-01
    “…Abstract Revascularization therapies, such as percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG), alleviate symptoms and treat myocardial ischemia. Patients with multivessel disease, particularly those undergoing 3-vessel PCI, are more susceptible to procedural complications, which can increase healthcare costs. …”
    Get full text
    Article
  13. 1373

    Risk of adverse cardiovascular events following spinal cord injury in patients with osteoporosis: Real-world evidence by Shih-Kai Kao, Yu-Ting Yu, Ming-Hsien Tsai

    Published 2025-03-01
    “…A Cox regression model was employed to estimate the hazard ratio (HR) for the primary outcomes: the development of acute myocardial infarction (AMI), atrial fibrillation (AF), or heart failure (HF). …”
    Get full text
    Article
  14. 1374

    HDAC Inhibition Modulates Cardiac PPARs and Fatty Acid Metabolism in Diabetic Cardiomyopathy by Ting-I Lee, Yu-Hsun Kao, Wen-Chin Tsai, Cheng-Chih Chung, Yao-Chang Chen, Yi-Jen Chen

    Published 2016-01-01
    “…The aim of this study was to investigate whether HDAC inhibitor, MPT0E014, can modulate myocardial PPARs, inflammation, and fatty acid metabolism in diabetes mellitus (DM) cardiomyopathy. …”
    Get full text
    Article
  15. 1375

    Functional Characterization of Preadipocytes Derived from Human Periaortic Adipose Tissue by Diana Vargas, Jaime Camacho, Juan Duque, Marisol Carreño, Edward Acero, Máximo Pérez, Sergio Ramirez, Juan Umaña, Carlos Obando, Albert Guerrero, Néstor Sandoval, Gina Rodríguez, Fernando Lizcano

    Published 2017-01-01
    “…Adipose tissues were collected from patients undergoing myocardial revascularization or mitral valve replacement surgery. …”
    Get full text
    Article
  16. 1376

    Mdivi-1 Protects CD4+ T Cells against Apoptosis via Balancing Mitochondrial Fusion-Fission and Preventing the Induction of Endoplasmic Reticulum Stress in Sepsis by You Wu, Yong-Ming Yao, He-Liang Ke, Lan Ying, Yao Wu, Guang-Ju Zhao, Zhong-Qiu Lu

    Published 2019-01-01
    “…Several studies have demonstrated that Mdivi-1, which is a selective inhibitor of the dynamin-related protein 1 (Drp1), attenuates apoptosis of myocardial cells and neurons during various pathologic states. …”
    Get full text
    Article
  17. 1377

    Mixture of MMP-2, MLC, and NOS Inhibitors Affects NO Metabolism and Protects Heart from Cardiac I/R Injury by Anna Krzywonos-Zawadzka, Aleksandra Franczak, Grzegorz Sawicki, Iwona Bil-Lula

    Published 2020-01-01
    “…Hence, an imbalance in nitric oxide (NO) metabolism along with oxidative stress is an important factor contributing to pathophysiology of cardiovascular disorders, including myocardial infarction. The aim of the current study was to provide an important insight into understanding the interaction of iNOS, eNOS, and ADMA during oxidative stress and to propose the beneficial therapy to modulate this interaction. …”
    Get full text
    Article
  18. 1378

    Older, vulnerable patient view: a pilot and feasibility study of the patient measure of safety (PMOS) with patients in Australia by Jeffrey Braithwaite, Natalie Taylor, Rebecca Lawton, Robyn Clay-Williams, Emily Hogden, Zhicheng Li

    Published 2016-06-01
    “…We aimed (1) to investigate the extent to which the PMOS is appropriate for use with stroke, acute myocardial infarction (AMI) and hip fracture patients in Australian hospitals and (2) to pilot the PMOS for use in a large-scale, national study ‘Deepening our Understanding of Quality in Australia’ (DUQuA).Participants Stroke, AMI and hip fracture patients (n=34) receiving care in 3 wards in 1 large hospital.Methods 2 phases were conducted. …”
    Get full text
    Article
  19. 1379

    Large Right Atrial Thrombus Associated with Central Venous Catheter Requiring Open Heart Surgery by Nasir Hussain, Paul Eric Shattuck, Mourad Hussein Senussi, Erwin Velasquez Kho, Mubeenkhan Mohammedabdul, Devang K. Sanghavi, Usman Mustafa, Arvind Balavenkataraman, Dragic M. Obradovic

    Published 2012-01-01
    “…Different pathogenic mechanisms have been postulated for the development of CRAT, which includes mechanical irritation of the myocardial wall, propagation of intraluminal clot, hypercoagulability, and hemodynamics of right atria. …”
    Get full text
    Article
  20. 1380

    The Relevance of Interventional Time and Clinical Outcomes in Patients with NSTEMI Based on the GRACE Score by Ji-Xiang Wang, Jing Gao, Jian-Yong Xiao, Ming-Dong Gao, Nan Zhang, Peng-Ju Lu, Yin Liu

    Published 2022-01-01
    “…To investigate the relevance between interventional time and clinical outcomes in non-ST-elevation myocardial infarction (NSTEMI) patients of different risk stratifications, which were divided into different groups according to GRACE scores and the time from admission to percutaneous coronary intervention (PCI). …”
    Get full text
    Article